Abstract: Provided are a composition for producing tagatose, comprising fructose-4-epimerase, and a method of producing tagatose using the same.

Abstract: A pH measuring device is disclosed. One aspect includes a body portion including a hollow portion therein and a through-portion formed in a first region so that the hollow portion communicates with the outside; an electrode unit including a reference electrode and a sensing electrode including different materials and configured to measure the pH in a living body by allowing a first end to be located in the hollow portion and a second end opposite to the first end to be exposed to the outside of the body portion through the through-portion; and a wireless communication unit configured to transmit a pH measurement value sensed by the electrode unit to the outside.

Abstract: Provided are a semiconductor memory device and a memory system including the same. The semiconductor memory device includes a power-up signal generator configured to generate a power-up signal in response to a memory voltage reaching a target voltage level, an initializer configured to generate an initialization signal in response to the power-up signal and a reset signal and to generate an initial refresh command in response to completion of an initialization operation, and a memory cell array including a plurality of memory cells connected between a plurality of word lines and a plurality of bit lines, the memory cell array configured to perform an initial refresh operation on the plurality of memory cells in response to the initial refresh command.

Abstract: Apparatus and methods are presented for using configurable additive data scrambling or descrambling circuitry for multichannel link aggregators in which a scrambler or descrambler polynomial is specified by binary data in a programmable register, and the polynomial data is used to compute a polynomial matrix. A scrambler or descrambler pattern is computed according to the polynomial matrix, and input data is bitwise exclusive-ORed with the computed scrambler or descrambler pattern to generate scrambled or descrambled output data. The scrambling or descrambling circuitry can be reconfigured for different polynomials by reprogramming the register, with the scrambler or descrambler automatically computing an updated polynomial matrix.

Abstract: The present invention relates to a novel promoter, a vector comprising the promoter, a microorganism comprising the promoter or the vector, and a method for producing a target product using the microorganism.

Abstract: The present invention relates to a composition for preventing and treating muscle diseases or improving muscular function, containing, as an active ingredient, at least one selected from the group consisting of morusin, kuwanon G, and a Mori Cortex Radicis extract. The Mori Cortex Radicis extract, morusin, or kuwanon G, according to the present invention, has an effect of remarkably enhancing muscular function by increasing the expression of p-mTOR protein involved in muscular protein synthesis, inhibiting the expression of mRNAs of MuRF-1 and atrogin-1 involved in muscular protein degradation, and increasing the expression of mRNAs of MyoD and myogenin involved in muscular differentiation. In addition, the present invention is a natural product so as to be used safely without side effects, thereby being usable in drugs, food, or cosmetics.

Abstract: Provided are a novel D-psicose 3-epimerase and a method for preparing psicose using the same.

Abstract: The present application relates to tofu comprising soy, allulose and a coagulant. The present application also relates to a method for manufacturing tofu using allulose.

Abstract: The present application relates to a composition for producing D-psicose comprising (a) a D-psicose 3-epimerase, a strain expressing the enzyme or a culture of the strain, and (b) at least one salt selected from the group consisting of an aluminate and an iodate, and a method for producing D-psicose from D-fructose or a method for increasing the conversion of D-fructose into D-psicose comprising adding (b) to (a).

Abstract: Provided are a composition for preparing D-psicose comprising a microorganism of the genus Kaistia, and a method for preparing D-psicose using the same.

Abstract: A hexuronate C4-epimerase with improved conversion activity and a method for producing D-tagatose using the hexuronate C4-epimerase. The hexuronate C4-epimerase includes an amino acid sequence set forth in SEQ ID NO: 1, in which serine (S) at position 125, serine (S) at position 185, valine (V) at position 267, serine (S) at position 268, threonine (T) at position 272, tryptophan (W) at position 306, arginine (R) at position 386 and tyrosine (Y) at position 403 from an N-terminal of hexunorate C4-epimerase are mutated.

Abstract: The present invention relates to a composition for preparing tagatose, wherein the composition is used for preparing tagatose from fructose and contains a protein including any one amino acid sequence of SEQ ID NOS: 1 to 7 or a microorganism expressing the protein. In addition, the present invention relates to a method for preparing tagatose from fructose, the method comprising a step of allowing the composition to react with fructose.

Abstract: Provided are a hexuronate C4-epimerase variant with improved activity in converting D-fructose by D-tagatose of hexuronate C4-epimerase and a method for production of D-tagatose using them.

Abstract: Provided are a composition for producing tagatose, comprising fructose-4-epimerase, and a method of producing tagatose using the same.

Abstract: The present invention relates to a composition for preventing or treating a muscle disorder, which includes a chrysanthemum extract or 3,5-dicaffeoylquinic acid as an active ingredient, and specifically, it may be used to reduce mRNA expression of atrogin-1 and MuRF1, which are main biomarkers involved in muscle protein degradation and increase mRNA expression of the mTOR protein, which is a main biomarker involved in muscle protein formation, and myogenin and MyoD, which are biomarkers related to muscle differentiation, thereby reducing muscle loss, and thus the chrysanthemum extract or 3,5-dicaffeoylquinic acid can be used in prevention and treatment of a muscle disorder, or improvement in muscle function. In addition, the chrysanthemum extract or 3,5-dicaffeoylquinic acid increases the activity of SIRT1 and PGC-1?, which are the main biomarkers involved in exercise performance, thereby excellently enhancing exercise performance.

Abstract: A display device includes: a substrate including a display region including a plurality of pixel regions, and a non-display region at a periphery of the display region; a pixel circuit layer including a plurality of circuit elements in the display region; a display element layer including a plurality of light emitting devices in the display region on the pixel circuit layer; and first and second alignment lines in the non-display region, the first and second alignment lines each having a multi-layered structure. Each of the first and second alignment lines includes: a main line in a same layer as at least one electrode in the display element layer; and at least one sub-line electrically connected to the main line, the at least one sub-line in a same layer as at least one electrode in the pixel circuit layer.

Abstract: Provided are a hexuronate C4-epimerase variant with improved activity in converting D-fructose by D-tagatose of hexuronate C4-epimerase and a method for production of D-tagatose using them.

Abstract: A manual shift lever system may be provided that includes: a shift lever which includes a rod and a stopper formed on the rod; a shift lock unit which limits a movement of the rod; and a control unit which, when a speed of a vehicle is greater than a critical speed of a predetermined gear limits the movement of the rod in a shift direction of the predetermined gear. The shift lock unit includes: at least one shift lock cam part including a main cam, a sub-cam, a shaft which functions as a rotating shaft of the main cam and the sub-cam, and a spring which connects the main cam and the sub-cam; a permanent magnet which is connected to the shift lock cam part; and an electromagnet arranged to have a polarity arrangement opposite to that of the permanent magnet.

Abstract: The present invention relates to a composition for muscle function improvement or exercise ability enhancement, the composition including kirenol, a Siegesbeckia herba extract, or a fraction of the Siegesbeckia herba extract as an active ingredient. Kirenol, the Siegesbeckia herba extract containing kirenol, or the Siegesbeckia herba extract fraction according to the present invention has an excellent effect of increasing muscle mass by increasing the protein expression of p-mTOR, which is a major gene concerned with muscle functions. Also, kirenol, the Siegesbeckia herba extract containing kirenol, or the Siegesbeckia herba extract fraction according to the present invention has an effect of remarkably enhancing exercise ability by increasing the protein expression of PGC-1?, which is a major gene concerned with exercise ability. In addition, the present invention is a natural product, and thus is safe for use without side effects and can be used as a medicine or food.

Abstract: The present disclosure relates to a novel promoter, a vector comprising the promoter, a microorganism comprising the vector, and a method for producing a target protein using the promoter.